Male contraception achievement of reversible azoospermia by combined gonadotropin releasing hormone antagonist and testosterone enanthate
Swerdloff, R.S.; Tom, L.K.S.; Salameh, W.; Steiner, B.; Peterson, M.; Rivier, J.; Vale, W.; Bhasin, S.
Contraception 46(2): 193-195
1992
ISSN/ISBN: 0010-7824 DOI: 10.1016/0010-7824(92)90039-vDocument Number: 321403
Document emailed within 0-6 h
Related Documents
Wallace, E.M.; Gow, S.M.; Wu, F.C. 1993: Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations Journal of Clinical Endocrinology and Metabolism 77(1): 290-293Kim, C.-H.; Ahn, J.-W.; You, R.-M.; Kim, S.-H.; Chae, H.-D.; Kang, B.-M. 2014: Combined administration of gonadotropin-releasing hormone agonist with human chorionic gonadotropin for final oocyte maturation in GnRH antagonist cycles for in vitro fertilization Journal of Reproductive Medicine 59(1-2): 63-68
Conn, P.M.; Rogers, D.; Seay, S. 1984: Gonadotropin releasing hormone stimulation of gonadotropin release from the pituitary regulation of cell responses and gonadotropin releasing hormone receptors by gonadotropin releasing hormone receptor micro aggregation Journal of Cellular Biochemistry Suppl (8 Part A): 233
Romerowicz-Misielak, M.; Tabecka-Lonczynska, A.; Koziol, K.; Gilun, P.; Stefanczyk-Krzymowska, S.; Och, W.; Koziorowski, M. 2016: Changes in gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor gene expression after an increase in carbon monoxide concentration in the cavernous sinus of male wild boar and pig crossbread Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 67(3): 431-442
Dubourdieu, S.; Charbonnel, B.; Massai, M.R.; Marraoui, J.; Spitz, I.; Bouchard, P. 1991: Suppression of corpus luteum function by the gonadotropin-releasing hormone antagonist Nal-Glu: effect of the dose and timing of human chorionic gonadotropin administration Fertility and Sterility 56(3): 440-445
Almond, G.W.; Esbenshade, K.L.; Smith, C.A.; Richards, R.G. 1992: Effects of chronic gonadotropin-releasing hormone agonist treatment on serum luteinizing hormone and testosterone concentrations in boars American Journal of Veterinary Research 53(1): 22-25
Zhang, P.; Song, K.; Li, L.; Yukuwa, K.; Kong, B. 2013: Efficacy of combined levonorgestrel-releasing intrauterine system with gonadotropin-releasing hormone analog for the treatment of adenomyosis Medical Principles and Practice: International Journal of the Kuwait University Health Science Centre 22(5): 480-483
Xue, S. 2000: A beam of dawn light of study on gossypol as a safe, effective, and reversible male antifertility contraceptive--evaluation of the studies by using low dose gossypol combined with steroid hormone for male contraception Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae 22(3): 211-213
Sharpe R.M. 1979: Modulation of prolactin luteinizing hormone and follicle stimulating hormone secretion by luteinizing hormone releasing hormone and bromocriptine cb 154 in the hypophysectomized pituitary grafted male rat and its effect on testicular luteinizing hormone receptors and testosterone output Biology of Reproduction 21(1): 141-148
Yang, T.S.; Wang, B.C.; Chang, S.P.; Ng, H.T. 1995: Comparison of human menopausal gonadotropin and follicle-stimulating hormone with gonadotropin-releasing hormone agonist desensitization for controlled ovarian hyperstimulation in in vitro fertilization Zhonghua Yi Xue Za Zhi 55(6): 452-456
Szilágyi, G.; Szabolcs, I.; Vydra, G.; Góth, M.; Irsy, G. 1984: Effect of thyrotropin-releasing hormone and gonadotropin-releasing hormone on serum TSH, PRL, hGH, FSH and LH in primary testicular failure and in hypogonadotrophic hypogonadism Acta Medica Hungarica 41(4): 175-183
Shastri, S.M.; Barbieri, E.; Kligman, I.; Schoyer, K.D.; Davis, O.K.; Rosenwaks, Z. 2011: Stimulation of the young poor responder: comparison of the luteal estradiol/gonadotropin-releasing hormone antagonist priming protocol versus oral contraceptive microdose leuprolide Fertility and Sterility 95(2): 592-595
Skoglund, R.D.; Paulsen, C.A. 1973: Danazole testosterone combination a potentially effective means for reversible male contraception a preliminary report Contraception 7(5): 357-365
Fulghesu, A.M.; Lanzone, A.; Guida, C.; Nicoletti, M.C.; Rossi, P.; Le Donne, M.; Caruso, A.; Mancuso, S. 1992: Ovulation induction with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression by gonadotropin releasing hormone agonist in polycystic ovary disease. a cross-over study Journal of Reproductive Medicine 37(10): 834-840
Long, Q.-q.; Zhang, S.-f.; Han, Y.; Chen, H.; Li, X.-l.; Hua, K.-q.; Hu, W.-g. 2010: Clinical efficacy and safety of gonadotropin releasing hormone agonist combined with estrogen-dydrogesteronea in treatment of endometriosis Zhonghua Fu Chan Ke Za Zhi 45(4): 247-251
Cetin, N.N.; Karabacak, O.; Korucuoglu, U.; Karabacak, N. 2009: Gonadotropin-releasing hormone analog combined with a low-dose oral contraceptive to treat heavy menstrual bleeding International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 104(3): 236-239
Richardson, B.A.; Petterborg, L.J.; Vaughan, M.K.; King, T.S.; Reiter, R.J. 1982: The effect of twice daily gonadotropin-releasing hormone (GnRH) administration and/or renal pituitary homografts on melatonin-induced gonadal atrophy in male Syrian hamsters Progress in Clinical and Biological Research 92: 129-142
Toth, T.L.; Awwad, J.T.; Veeck, L.L.; Jones, H.W.; Muasher, S.J. 1996: Suppression and flare regimens of gonadotropin-releasing hormone agonist. Use in women with different basal gonadotropin values in an in vitro fertilization program Journal of Reproductive Medicine 41(5): 321-326
Petraglia, F.; Genazzani, A.D.; Aguzzoli, L.; Gallinelli, A.; de Vita, D.; Caruso, A.; Genazzani, A.R. 1994: Pulsatile fluctuations of plasma-gonadotropin-releasing hormone and corticotropin-releasing factor levels in healthy pregnant women Acta Obstetricia et Gynecologica Scandinavica 73(4): 284-289
Manetta, L.A.; de Paula Martins, W.; Rosa e Silva, J.úl.C.és.; de Sá Rosa e Silva, A.C.J.; Nogueira, A.ôn.A.; Ferriani, R.A. 2008: Uterine ultrasonographic changes during endometriosis treatment: a comparison between levonorgestrel-releasing intrauterine devices and a gonadotropin-releasing hormone agonist Ultrasound in Medicine and Biology 34(12): 1914-1918